Clinical Trials Browser

Phase 2 × Neurilemmoma × 1 year × Clear all

Schwannomatosis, Neurilemmoma, Pain, Chronic Pain

NCT06322342 2025-12-26

Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent

Neuroinflammatory Diseases, Brain Neoplasms, Glioma, Meningioma, Multiple Sclerosis, Neoplasms, Neurilemmoma, Neurofibroma, Neuroma, Acoustic, Central Nervous System Neoplasms

Clinical Trials

Screening Trial for Pain Relief in Schwannomatosis (STARFISH)

Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent